Replies to post #3623 on Galectin Therapeutics Inc. (GALT)

[jimmy667]

I see no news to support a 9% jump in price this morning. Rumour of FDA acceptance of the trial protocol maybe? What have other companies spent on Phase 3 NASH? Will $40-50 million be enough to go alone on this?